Company intelligence / Profile preview

SolarToday

Ownership: Private
Development stage: Commercial

Overview

Solar Biotech specialized in developing and commercializing sustainable microbial biomanufacturing technologies using proprietary strains and modular plant architectures. It enabled the production of proteins, biooils, carotenoids, and other ingredients for food, beverage, and cosmetic industries through clean precision fermentation. The company became profitable early but overexpanded leading to bankruptcy in mid–2024. Its assets were acquired by Pictor Biotech.

Industry: Non-Drug Biotech

Partnerships

Ingredion

Beyond the preview

Go deeper on SolarToday.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SolarToday.

Explore the full profile